Boesen Biotech ApS: Financial statements 2024
CVR: 39142635
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Boesen Biotech ApS (CVR 39142635) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -21,066 and a net result of DKK 723,812 compared with DKK -3,967,498 the year before. Equity in the 2024 report amounted to DKK 1,456,714. The solvency ratio was 24%.
- Gross Profit
- DKK -21,066
- Profit/Loss
- DKK 723,812
- Equity
- DKK 1,456,714
- Total Assets
- DKK 6,061,794
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -21K | 724K | 1.5M | 0 |
| 2023 | - | -28K | -4M | 733K | 0 |
| 2022 | - | -36K | -5.5M | 4.7M | - |
| 2021 | - | -34K | 8.1M | 10.2M | - |
| 2020 | - | -21K | 2.3M | 2.1M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Boesen Biotech ApS has published its annual report for 2023. Gross profit came to DKK -28,051, and the net result was DKK -3,967,498.
As of June 26, 2024, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of Boesen Biotech ApS.
As of February 27, 2024, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of Boesen Biotech ApS.
As of February 27, 2024, EY Godkendt Revisionspartnerselskab has stepped down as auditor of Boesen Biotech ApS.
About Boesen Biotech ApS
Boesen Biotech ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Thomas Boesen. The company is owned by T. BOESEN HOLDING ApS and Gudter ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -54,998 and a net result of DKK 2,039,886 compared with DKK 723,812 the year before. Equity in the 2025 report amounted to DKK 3,496,600.